SCHEMBL6271696

SCHEMBL6271696

C=C(Cn1c(N)nc2[nH]cnc2c1=O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 2/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CCNB1 P14635 1/20 0.39
▸ MGMT P16455 1/20 0.39
▸ CCNA2 P20248 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ CCNA1 P78396 1/20 0.39
▸ MAOA P21397 2/20 0.33
▸ MAOB P27338 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ PDPK1 O15530 1/20 0.33
▸ ADORA3 P0DMS8 2/20 0.32
▸ ADORA2B P29275 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ PDE4A P27815 2/20 0.32
▸ PDE4B Q07343 2/20 0.32
▸ PDE4C Q08493 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6267419 0.87 PNP (0.40) PNPKDM4EKMT2A
SCHEMBL6265529 0.81 PDE4A (0.34) PNPCDK1CCNB1MGMTCCNA2
SCHEMBL6271705 0.81 CDK1 (0.52) PNPCDK1CCNB1MGMTCCNA2
SCHEMBL5048171 0.81 PNP (0.39) PNPALDH1A1ADORA2BKDM4EPDE4A
SCHEMBL6266771 0.79 CDK1 (0.36) PNPCDK1CCNB1MGMTCCNA2
SCHEMBL18247 0.79 PNP (0.59) PNPALDH1A1ADORA3ADORA2BKDM4E
SCHEMBL6271387 0.78 CDK1 (0.37) PNPCDK1CCNB1CCNA2CDK2
SCHEMBL1980958 0.78 PNP (0.57) PNPALDH1A1ADORA3ADORA2BKDM4E
SCHEMBL6265333 0.77 PDE4A (0.46) PNPMGMTADORA2BPDE4APDE4B
SCHEMBL6268523 0.77 ADORA2B (0.53) PNPALDH1A1MAPK1ADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017394-B1 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER REC TECH LTD (GB) 2005-12-07 — — EP disclosed
US-6303618-B1 ADMINISTERING PURINE COMPOUND WHICH INHIBITS CYCLIC DEPENDENT KINASE ACTIVITY FOR THERAPY OF TUMOR OR OTHER CELL PROLIFERATION DISORDER CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2001-10-16 — — US disclosed
Send feedback